The preclinical results were highlighted at the AACR Annual Meeting in Chicago, Illinois, on April 28, 2025, drawing attention to Portage’s advances in immuno-oncology. The company is now preparing to ...

Investing.com — Portage Biotech Inc (NASDAQ: PRTG )股价在盘前交易中飙升33.9%，此前该公司宣布了PORT-7治疗间皮瘤的确证性临床前有效性数据。这些支持推进至首次人体试验的数据由著名间皮瘤专家Luciano ...

U.S. stock futures are little changed as markets enter the week on a four-session winning streak and investors prepare for a ...

Investors hope for more progress on tariff deals. Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Merck KGaA agreed to buy SpringWorks Therapeutics Inc., a maker of medicines for cancer and rare diseases, to boost its ...

Biotech company Regeneron (NASDAQ:REGN) will be reporting earnings tomorrow morning. Here’s what you need to know.

FRANKFURT (REUTERS) -German healthcare and materials group Merck KGaA said on Monday it struck a deal to acquire U.S. biotech ...

While technology may continue to be an excellent investment and repeat its outstanding returns of the past five years, the recent short-term sell-off flags the possibility of a significant slump and ...

Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...

As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...